About Compugen Ltd. - CGEN.TA
Compugen Ltd. is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies for the treatment of cancer and other diseases through computational predictive biology. The company leverages computational methods to analyze biological data and identify potential drug targets.
What are Compugen Ltd.'s core values and mission statement?
Compugen Ltd., focusing on computational genomics to discover novel drug targets, typically emphasizes innovation, collaboration, and excellence as core values, aiming to leverage their scientific expertise in predictive discovery to deliver transformative medicines to patients. Please check their official website or latest publications for the most accurate and current mission statement and values.
Who founded Compugen Ltd. and when?
Compugen Ltd. was founded in 1993 by a team of scientists including Simchon Faigler and Amir Natan.
Who leads Compugen Ltd.?
As of the last available information, the CEO of Compugen Ltd. is Anat Cohen-Dayag. Please note that executive positions can change and for the most current information, a visit to the company's official website or a review of their latest press releases would be recommended.
Where is Compugen Ltd. located, and what is its base country?
Compugen Ltd. is headquartered in Holon, Israel, which is its base country.
On which exchanges is Compugen Ltd. traded?
Compugen Ltd. is traded on the NASDAQ under the ticker symbol CGEN.
Compugen Ltd. (CGEN) Price Live Data
The live price of Compugen Ltd. (CGEN) is $2.73, with a trading volume of 203,923 in the last 24 hours. Wrapstocks updates the CGEN price in real-time. Compugen Ltd. is up 0.99% in the last 24 hours. The company has a live market cap of $241,258,429.81 and a supply of 88,327,199 CGEN stocks.
Compugen Ltd. (CGEN) is traded on Tel-Aviv Stock Exchange, and currently, the market is closed; trading will be resumed in 3 hours and 1 minutes.